Virus News and Research

Latest Virus News and Research

Understanding infection risks in pediatric hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

7 Feb 2025

Rwanda's swift response contained Marburg outbreak

In July 2024, Rwanda faced a Marburg virus outbreak among health workers in the capital Kigali, challenging the nation’s health system and testing its pandemic response capabilities.

7 Feb 2025

New gene modification enhances CAR-T cell effectiveness against cancer

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for an extended period, potentially reducing the chance of cancer recurring.

7 Feb 2025

Measles outbreak mounts among children in one of Texas’ least vaccinated counties

A measles outbreak is growing in a Texas county with dangerously low vaccination rates.

7 Feb 2025

On the front lines against bird flu, egg farmers say they’re losing the battle

Greg Herbruck knew 6.5 million of his birds needed to die, and fast.

7 Feb 2025

Urban density and HIV prevalence linked to rising antibiotic resistance in gonorrhea

Researchers identify key geographic and health factors that may predict the prevalence of antimicrobial-resistant gonorrhea in the United States.

7 Feb 2025

Study explores the impact of respiratory bacteria on RSV severity

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare systems worldwide.

6 Feb 2025

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

6 Feb 2025

Jumbo phages' protective shield offers clues for fighting antibiotic resistance

Scientists are learning more about how an intriguing type of virus protects itself. Revealing its strategies could boost the fight against antibiotic resistance.

6 Feb 2025

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU in 2022.

5 Feb 2025

COVID-19 speeds up artery plaque growth, raising heart disease risk

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk plaques, even in non-hospitalized individuals.

5 Feb 2025

The link between air pollution and lower respiratory infections in adults

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, highlighting urgent health concerns.

5 Feb 2025

New insights into how the Sudan virus attaches to human cells

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.

4 Feb 2025

New gene therapy shows promise for lifelong treatment of hypophosphatasia

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.

4 Feb 2025

Uganda launches first ever vaccine trial for Sudan Ebola virus

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners today launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency.

4 Feb 2025

In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic.

4 Feb 2025

USC receives $6 million grant for pioneering glioblastoma gene therapy

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first-of-its-kind genetic therapy for glioblastoma, a severe form of brain cancer.

3 Feb 2025

New study confirms CAR T cell therapy does not cause secondary cancers

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, according to new analysis reported today in Nature Medicine from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

3 Feb 2025

Pasteurization destroys influenza viruses in milk, reinforcing dairy safety

Pasteurization at 63°C and 72°C effectively inactivates influenza A viruses in milk, ensuring its safety for human consumption while viral RNA may still be detected.

2 Feb 2025

New method can neutralize coronaviruses with mineral nanoparticles

A new way to neutralize the coronavirus and other membrane-surrounded viruses has been discovered by researchers from the Swedish University of Agricultural Sciences and the University of Tartu.

31 Jan 2025